secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001683168-24-002881
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

PharmaCyte Biotech shareholders elect all five directors and approve auditor ratification at 2024 annual meeting
--------------------------------------------------------------------------------

- Quorum of 53.41% of outstanding shares represented at the April 29, 2024 annual meeting.
- All five director nominees elected: Silverman, Schechter, Abecassis, Weinstein, and Walker, each with approximately 88-93% of votes cast For.
- Ratification of Marcum LLP as independent auditor approved with 4,387,273 For, 109,167 Against, 18,447 Abstain.
- Non-binding advisory vote on executive compensation passed with 1,922,352 For, 186,215 Against, 50,866 Abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316824002881/0001683168-24-002881-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316824002881/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-002881

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer